Cabaltera, Sweet Mary P.

HRN: 11-47-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2023
CEFTRIAXONE 1G (VIAL)
01/12/2023
01/18/2023
IVT
2 G
Once A Day
T/c Infectious Diarrhea, Leukocytosis
Waiting Final Action 
01/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/13/2023
01/19/2023
IVT
500 Mg
Q8
Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: